ArticleBMC microbiology2025
The relationship between vaginal and endometrial microbiota and the outcome of Frozen-Thawed embryo transfer during hormone replacement cycles.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo investigate whether vaginal and endometrial microbiota impact pregnancy outcomes in frozen embryo transfers (FET) during hormone replacement cycles.
methodsThis retrospective cohort study analyzed 51 first-time FET patients from January 2021 to December 2022. Using 16 S rRNA sequencing, patients were stratified based on uterine microbiota composition into Lactobacillus-dominant (LD, 20 cases) and non-Lactobacillus-dominant (NLD, 31 cases) groups based on uterine microbiota. Vaginal (A1, A2) and uterine (B1, B2) microbiota were compared, along with pregnancy outcomes.
resultsSequencing yielded 5,753,727 valid sequences and 1,545 OTUs. Alpha diversity showed lower Shannon index (P=0.034) and higher Simpson index in B1 vs. B2 (P=0.017), indicating reduced diversity in B1. Beta diversity analysis revealed more concentrated and similar microbial composition in B1, with significant differences between B1 and B2 (Anosim R = 0.3812, P = 0.001). B1 had higher abundance of Firmicutes and Lactobacillus, while B2 had more Proteobacteria and potential pathogens. Clinical pregnancy rate (75.00%) and live birth rate (65.00%) were higher in LD compared to NLD (45.16% and 29.03%, respectively, P = 0.036 and P = 0.011).
conclusionVaginal microbiota do not fully reflect uterine microbiota. Dominance of Lactobacillus in the uterine microbiome is beneficial for favorable FET outcomes, while the presence of non-Lactobacillus dominant species may negatively impact FET results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.